
Company valuation, historical trends, and peer comparisons.
According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 964.94M. This represents a change of -66.95% compared to the average of 2.92B of the last 4 quarters.
The mean historical Enterprise Value of Structure Therapeutics Inc. over the last ten years is 1.44B. The current 964.94M Enterprise Value has changed -33.19% with respect to the historical average. Over the past ten years (40 quarters), GPCR's Enterprise Value was at its highest in in the June 2026 quarter at 3.63B. The Enterprise Value was at its lowest in in the December 2021 quarter at 0.
Average
1.44B
Median
1.10B
Minimum
846.60M
Maximum
3.32B
Discovering the peaks and valleys of Structure Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 163.41%
Maximum Annual Enterprise Value = 3.32B
Minimum Annual Increase = -9.48%
Minimum Annual Enterprise Value = 846.60M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.32B | 163.41% |
| 2024 | 1.26B | -8.08% |
| 2023 | 1.37B | 48.35% |
| 2022 | 925.46M | 9.31% |
| 2021 | 846.60M | -9.48% |
The current Enterprise Value of Structure Therapeutics Inc. (GPCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.99B
5-year avg
1.55B
10-year avg
1.44B
Structure Therapeutics Inc.’s Enterprise Value is less than Septerna Inc (1.96B), greater than MetaVia Inc. (-4617160.00), greater than Biomea Fusion, Inc. (12.39M), less than Kailera Therapeutics, Inc. (1.53B), greater than vTv Therapeutics Inc. (10.98M), greater than BioAge Labs Inc. (144.20M), less than Maze Therapeutics, Inc. (1.56B), less than Mineralys Therapeutics, Inc. (1.46B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.96B | $2.02B | |
| -4617160.00 | $7.84M | |
| 12.39M | $46.34M | |
| 1.53B | $1.65B | |
| 10.98M | $97.62M | |
| 144.20M | $215.33M | |
| 1.56B | $1.70B | |
| 1.46B | $1.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Structure Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Structure Therapeutics Inc. (GPCR)?
What is the 3-year average Enterprise Value for Structure Therapeutics Inc. (GPCR)?
What is the 5-year average Enterprise Value for Structure Therapeutics Inc. (GPCR)?
How does the current Enterprise Value for Structure Therapeutics Inc. (GPCR) compare to its historical average?